Clinical Trials Logo

Colonic Neoplasms clinical trials

View clinical trials related to Colonic Neoplasms.

Filter by:

NCT ID: NCT03277235 Not yet recruiting - Colon Cancer Clinical Trials

Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients

Start date: September 2017
Phase: N/A
Study type: Interventional

The aims of this three-year study are to explore the protective and risk factors of resilience in colorectal cancer patients, and examine the effect of the resilience model-based care plan in reducing fear of recurrence and GI symptom distress and improving quality of life in newly diagnosed colorectal cancer (CRC) patients.

NCT ID: NCT03259828 Completed - Sigmoid Cancer Clinical Trials

Sigmoid Colon Organ Motion in Radiotherapy

Start date: December 6, 2017
Phase: N/A
Study type: Interventional

Radiotherapy is used in cancer treatment to eradicate microscopic cancer cells to lower the risk of recurrence. The radiotherapy plan must account for organ movement inside the body to ascertain adequate dose is delivered to the target. Knowledge of the magnitude is crucial to radiotherapy treatment planning. This study aims to quantify the movement of the sigmoid colon between different fractions of radiotherapy treatment (interfraction motion) and within the same fraction (intrafraction motion). This knowledge will help us determine the optimal margin to use in radiotherapy treatment planning.

NCT ID: NCT03255434 Active, not recruiting - Clinical trials for Stage III Colon Cancer

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

LEANOX
Start date: November 1, 2017
Phase: Phase 2
Study type: Interventional

Cytotoxic chemotherapy is usually scaled to the body surface area (BSA), and is currently not adjusted to the body proportions of lean and fat (i.e. body composition) of individual patients. Patients with low muscle mass behave like patients "overdosed" with chemotherapy resulted in dose-limiting toxicities (e.g. dose reductions, treatment delays or permanent treatment discontinuation), independently of the patient's weight.

NCT ID: NCT03254498 Completed - Colonic Neoplasms Clinical Trials

Detection in Tandem Endocuff Cap Trial

DETECT
Start date: April 2016
Phase: N/A
Study type: Interventional

A randomised back to back study comparing cap and Endocuff to detect adenomas during colonoscopy

NCT ID: NCT03246438 Completed - Cancer of Colon Clinical Trials

Choice Architecture and Colorectal Cancer Screening Outreach

Start date: November 14, 2017
Phase: N/A
Study type: Interventional

This pilot study is a 3-arm randomized control trial assessing the effectiveness of sequential or active choice in CRC (colorectal cancer) screening outreach vs. colonoscopy outreach only, in patients between 50-74 years old, who have received care at the University City or Valley Forge CCA (Community Care Associates) practices, are due for screening, and are asymptomatic for CRC. The three arms are: Arm 1: Direct schedule colonoscopy (Control), Arm 2: Direct schedule colonoscopy followed by mailed FIT(Fecal Immunochemical Test) (Sequential Choice), and Arm 3: Choice of direct schedule colonoscopy or mailed FIT (Active Choice).

NCT ID: NCT03231917 Completed - Colonic Neoplasms Clinical Trials

Water Immersion and Polyp Detection: A Randomized Controlled Trial

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

We plan to conduct a randomized trial of tandem colonoscopies comparing water infusion and air insufflation for inspection of mucosa on withdrawal. In one randomized group, water infusion will be employed as the first method for mucosal inspection while in a second group, CO2 insufflation will be used first. This study will be different than usual care since the participants will receive two successive or tandem colonoscopies versus one

NCT ID: NCT03213444 Completed - Colon Cancer Clinical Trials

Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

Start date: July 2015
Phase: N/A
Study type: Interventional

The present study aims to investigate the impact of adjuvant chemotherapy with 5-FU isolated and associated with oxaliplatin in cardiac autonomic control and endothelium-dependent vascular function in patients undergoing colectomy for stages II and III colon cancer. Will be performed evaluation of cardiac and vascular function, autonomic control, functional capacity and blood evaluations.

NCT ID: NCT03210129 Completed - Endometrial Cancer Clinical Trials

Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients

MIPAClux
Start date: July 6, 2017
Phase: N/A
Study type: Interventional

Physical activity is not only efficient for primary prevention of several cancer types, but it also plays an important role in cancer survivors. Physical activity after a cancer diagnosis has been associated with reduced overall and cancer-specific mortality. It has significant positive effects on physical fitness and several cancer-related symptoms including fatigue, sleep disturbance, depression and anxiety. The evidence is considerable and consistent for breast, colorectal and endometrial cancers. However, patients are generally insufficiently active, and participation rates in physical activity opportunities offered by specialized organizations are low. This pilot study will evaluate the feasibility, efficacy and cost-effectiveness of an intervention seeking to increase active lifestyle and physical activity participation of cancer patients. To encourage this behavioural change, motivational interviewing will be used, a patient-centred approach aimed at increasing the patients' motivation for a behavioural change through open-ended discussions. Seventy patients with breast, colorectal or endometrial cancer will be recruited within a time period of 12 months. Patients will be randomly assigned to an intervention or a control group. The intervention group will receive standard care alongside 12 motivational interviewing sessions within 12 weeks. The control group will receive standard care only. Physical activity behaviour (3D-accelerometer) and physical fitness (cardiovascular and strength fitness) will be measured in the week preceding and following the intervention. Additionally, a subgroup from both study arms will be assessed 12 weeks after the completion of the intervention. The investigators hypothesize that sedentary time will decrease and time spent in moderate and vigorous physical activity, physical fitness and quality of life of cancer survivors will increase to a greater extent in the intervention group than in the control group. Furthermore, health-related quality of life and resource use (intervention and healthcare costs, out of pocket costs) will be measured to evaluate the cost-effectiveness of the intervention.

NCT ID: NCT03200834 Active, not recruiting - Colon Cancer Clinical Trials

Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)

Start date: January 25, 2017
Phase: N/A
Study type: Interventional

Comparing different method of surgical technique D2 lymph node dissection vs D3 for right colon cancer.

NCT ID: NCT03199989 Recruiting - Clinical trials for Adjuvant Chemotherapy

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)

EPAC1
Start date: June 1, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to design a prospective randomized clinical trial to explore whether postoperative adjuvant chemotherapy may provide survival benefit for stage II colon cancer patients with high risk factors.Therefore the investigators can provide high level clinical evidence of indications for patients with colon cancer with stage II colon cancer.